Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Scherbacher, Paul [VerfasserIn]   i
 Hellmich, Bernhard [VerfasserIn]   i
 Feng, You-Shan [VerfasserIn]   i
 Löffler, Christian [VerfasserIn]   i
Titel:Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis
Verf.angabe:Paul J Scherbacher, Bernhard Hellmich, You-Shan Feng, Christian Löffler
E-Jahr:2024
Jahr:February 29, 2024
Umfang:8 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 12.07.2024
Titel Quelle:Enthalten in: RMD Open
Ort Quelle:London : BMJ Publishing Group, 2015
Jahr Quelle:2024
Band/Heft Quelle:10(2024), 1 vom: Feb., Artikel-ID e003956, Seite 1-8
ISSN Quelle:2056-5933
Abstract:Objective Glucocorticoids (GC) are a cornerstone in treating antineutrophil cytoplasmic antibodies-associated vasculitides (AAV), however, they add to morbidity and mortality. To date, GC toxicity in AAV has rarely been systematically investigated. - Methods Patients with a confirmed AAV were included in this monocentric prospective study. GC toxicity was assessed by structured interviews, clinical examination and electronic medical record analysis. The Glucocorticoid Toxicity Index (GTI) consisting of the Aggregate Improvement Score (GTI-AIS) and the Cumulative Worsening Score (GTI-CWS) was assessed at two time points (t1 baseline, t2 6 months later). We used regression analyses to assess the relationship between GTI and GC exposure, toxicity, and disease activity, and a receiver operating characteristic analysis to calculate a GC threshold dose beyond which toxicity is expected to occur. - Results We included 138 patients with AAV. The median cumulative GC dose was 9014.0 mg. The most frequent adverse events were skin atrophy, osteoporosis and myopathy. GC exposure and toxicity were significantly correlated (p<0.001). GTI-AIS was significantly higher in active disease compared with patients in remission (p<0.001). GTI-CWS scored significantly higher in long-standing diseases (p=0.013) with high cumulative GC doses (p=0.003). Patients with a cumulative GC dose of 935 mg or more showed an 80% likelihood for a clinically meaningful change in GTI scoring. - Conclusion The GTI is capable of capturing GC toxicity in AAV and identifies patients at increased risk for GC side effects. Our data support efforts to limit GC exposure in patients with AAV.
DOI:doi:10.1136/rmdopen-2023-003956
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1136/rmdopen-2023-003956
 kostenfrei: Volltext: https://rmdopen.bmj.com/content/10/1/e003956
 DOI: https://doi.org/10.1136/rmdopen-2023-003956
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Glucocorticoids
 Granulomatosis with polyangiitis
 Systemic vasculitis
 Vasculitis
K10plus-PPN:1895241138
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69233146   QR-Code
zum Seitenanfang